Parkinson's isn't fatal — but it can lead to these complications which are, as Ozzy Osbourne dies at 76
Parkinson's, which affects memory, thinking and movement, is the fastest-growing neurological condition in the world.
Osbourne was diagnosed with Parkinson's in 2003, but waited until 2020 to publicly disclose the news.
6 Ozzy Osbourne was diagnosed with Parkinson's in 2003, but waited until 2020 to publicly disclose the news.
Cameron Glendenning
He was open about his health struggles in recent years.
'It's been five years of absolute hell for me and the family,' the 'Prince of Darkness' said on 'Piers Morgan Uncensored' in September 2023.
Around 90,000 new cases of Parkinson's are diagnosed in the US each year. The disease tends to strike people over the age of 60.
Osbourne and the actor Michael J. Fox, 64, are among the most prominent patients.
While the exact cause of Parkinson's remains unknown, some experts propose it might originate in the gut before affecting the brain.
The disorder commonly affects mobility, causing shaking and stiffness as well as hindering balance and coordination.
6 Osbourne is seen leaving an office building in Santa Monica, Calif., in November 2023.
Clint Brewer Photography / A.I.M / BACKGRID
There is no known cure for Parkinson's, and while the disease itself isn't fatal, it is progressive and can cause life-threatening complications.
'You wake up the next morning and find that something else has gone wrong,' Osbourne told The Guardian. 'You begin to think this is never going to end.'
Here are some of the things that can go wrong with Parkinson's and lead to death.
Pneumonia
According to an NIH study, aspiration pneumonia accounts for 70% of deaths among Parkinson's patients.
The infection occurs when bacteria from the mouth are pulled into the lungs during aspiration, i.e., when a person swallows the wrong way and something enters their airway or lungs.
Parkinson's patients are more likely to aspirate since dysphagia, or difficulty swallowing, is a common symptom of the disease.
It is estimated that around 80% of patients suffer from this kind of issue in the early stages of the disease. The incidence increases to 95% in later stages.
6 Parkinson's patients are more likely to aspirate since dysphagia, or difficulty swallowing, is a common symptom of the disease.
Pixel-Shot – stock.adobe.com
The risk of aspiration pneumonia can be mitigated by preventing swallowing issues and reducing mouth bacteria with vigilant oral hygiene.
Malnutrition
A study in the Journal of Parkinson's Disease found that roughly 30% of patients with mild to moderate Parkinson's are at risk for malnutrition.
Malnutrition weakens the immune system, making individuals with Parkinson's more susceptible to infections. In addition, malnutrition can amplify other Parkinson's symptoms like fatigue, cognitive decline and mood disturbance.
Blood clots
Blood clots, or venous thrombosis, rank among the leading causes of sudden death in Parkinson's patients.
Deep vein thrombosis, or DVT, occurs when a blood clot forms in a deep vein due to slow or blocked blood flow. It's often caused by sitting in the same position for a long time.
An estimated 1 million Americans develop DVT annually, and up to 100,000 will die from it.
6 Blood clots are more common in patients with Parkinson's compared to the general population.
Doodeez – stock.adobe.com
The incidence of DVT is notably higher in Parkinson's patients than in the general population.
Most Parkinson's patients suffer from bradykinesia, hindered mobility, as well as swelling and pain in their lower extremities.
In early Parkinson's patients, bradykinesia can cause abnormal muscle contractions and limit the pumping function in the leg muscles, leading to impaired blood flow and an increased likelihood of blood clots.
6 Osbourne is seen exiting a car with a cane in May 2024.
SplashNews.com
Advanced Parkinson's patients face an even higher risk of blood clots due to postural imbalance and being bedridden.
'I also get blood pressure issues, from blood clots on my legs. I'm used to doing two hours on stage, jumping and running around,' Osbourne told The Guardian this year.
Sepsis
Relative to immobility, advanced-stage Parkinson's patients are more likely to develop pressure ulcers, also known as bedsores.
According to the American Parkinson's Disease Association, these ulcers can become infected and, if left untreated, can lead to a life-threatening condition known as sepsis.
Falls
Due to the balance and mobility issues caused by Parkinson's, patients are at a higher risk of falling, which can result in head injuries, broken bones or even death.
6 Unintentional falls are the leading cause of injury and deaths in seniors.
Daniel – stock.adobe.com
Death rates from unintentional falls rose more than 70% from 2003 to 2023 for people 65 to 74, according to data.
The rate increased by over 75% for adults 75 to 84 and more than doubled for seniors 85 and older.
Dementia
Parkinson's dementia is a decline in cognitive function that occurs after a Parkinson's diagnosis.
It develops at least one year — but usually longer — after the diagnosis.
Symptoms of Parkinson's dementia include a decrease in memory, trouble focusing, challenges with language, mood changes, muffled speech, apathy and psychosis.
The longer a patient lives with Parkinson's, the more likely they are to develop the related dementia.
Osbourne's official cause of death has yet to be publicly announced.
On July 5, he played his final show with Black Sabbath in his hometown of Birmingham, England.
The event raised $190 million for several UK charities, including Cure Parkinson's.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
2 hours ago
- Axios
A majority of North Carolinians oppose cutting federal funding for research, poll finds
Nearly 60% of North Carolinians oppose large-scale federal funding cuts to medical research, a new survey has found. Why it matters: The Trump administration has proposed sweeping cuts to federal research funding, including $20 billion from the National Institutes of Health. That could have significant ramifications in North Carolina, where Duke University and UNC-Chapel Hill are among the largest recipients of research funding from the NIH. Already, the Trump administration has tried to change how the federal government covers indirect costs for research, which could lead to large funding decreases in the Triangle. However, that decision has been stopped in the courts. Between the lines: The poll was commissioned by United for Cures, a group backed by UsAgainstAlzheimer's, which opposes the Trump administration's cuts to the NIH. The poll was conducted by the firm Public Opinion Strategies, which surveyed 500 registered voters in North Carolina between June 23-26. Zoom in: Of the survey respondents who said they oppose cutting medical research, 48% said they strongly opposed it, according to Public Opinion Strategies. A large majority of those opposed to the cuts say they are worried about research being cut for cancer treatments and prevention. Many of the respondents said the cuts could affect how they vote, with 56% saying they would be less likely to vote for a member of Congress who voted for the cuts. Among self-described moderate voters, that share reaches 63%. On the other side, 33% of respondents said they favored cutting funding for medical research, and 25% said they would be more likely to vote for a member of Congress who voted for the cuts.
Business Insider
8 hours ago
- Business Insider
IBM and Cleveland Clinic Build an AI Model that Predicts Brain Disorders
The way people walk, their gait, can reveal early signs of serious neurological conditions such as Parkinson's disease, cerebral palsy, dementia, and cognitive decline. Subtle differences in stride, balance, and timing often give clues about these conditions, but traditional gait assessments rely heavily on visual observation by doctors. This approach can be subjective, time‑consuming, and limited to controlled environments. However, a new collaboration between tech giant IBM (IBM) and Cleveland Clinic hopes to change this by creating an AI system that can work with many types of neurological conditions and sensor setups, including everyday devices like smartphone cameras and wearables. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. At the center of this work is an AI foundation model called GaitFM, trained on a mix of real and synthetic data. Most of the training data comes from physics‑based simulations of walking that mimic the effects of age, disease, and different types of sensors. This synthetic data helps solve a major problem in gait research: there is very little gait data available online. By first training on synthetic data and then fine‑tuning with smaller clinical datasets, GaitFM can recognize the gait patterns of different diseases. Early tests show that GaitFM can estimate key movement features, classify conditions, and even predict disease progression. In studies, models trained on synthetic data alone were able to perform competitively, and combining synthetic with real data provided the best results. The technology is already being piloted at Cleveland Clinic and recently won Best Paper at the 2025 IEEE International Conference on Digital Health. Researchers believe this approach could make gait analysis widely accessible and scalable, especially for rare conditions where collecting real data is difficult. Is IBM a Buy, Sell, or Hold? Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on seven Buys, four Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $297.33 per share implies 14.5% upside potential.
16 hours ago
Confusion at NIH as administration halts, then releases, billions of dollars for scientific research
Billions of dollars of National Institutes of Health research were stuck in limbo for hours, causing confusion after a memo from the Office of Management and Budget appeared to direct a halt to its funding. The funding halt at NIH came after an OMB memo's footnote was interpreted to mean the release of money for research grants was prohibited, according to an email sent to NIH staff Tuesday afternoon by its associate director for budget, Neil Shapiro. "We are working to make this limitation short-term and temporary," Shapiro wrote in the email. This back-and-forth comes after a string of large-scale cuts at the Health and Human Services Department, led by Secretary Robert F. Kennedy Jr., that has cast agencies such as NIH, the Food and Drug Administration and the Centers for Disease Control and Prevention into confusion as they execute directives from the top. Following reporting by several outlets, OMB reversed the decision publicly, with a spokesperson saying on Tuesday evening the money was "undergoing a programmatic review" but "is being released." Confusion remained at NIH, however. At almost the same time OMB publicly said the funding halt wasn't happening, NIH leadership emailed staff that it was still "only authorized to obligate funds" for limited purposes such as salaries and clinical expenses, but that "NIH leadership is diligently working to resolve this issue and hopes to provide further updates soon." And on Wednesday morning, regular processes were gummed up briefly by the confusion, including credit card purchase approvals. An email sent to a group of agency employees who approve credit card purchases indicated the halt was still in effect, saying "a pause on the obligation of funds pertaining to the conduct of research and development," with a promise to keep the group updated with any changes to the new requirements. Two hours later, those same employees were informed the halt had been lifted. The funding freeze would've impacted approximately $15 billion in funding that would be given to research institutions around the country between now and Sept. 30, according to an estimate from Democratic Sen. Patty Murray of Washington, a high-ranking official on the Senate Appropriations Committee. "What is stunning to me is that OMB is saying that these funds are being released, while HHS is saying exactly the opposite—the chaos and dysfunction of the Trump administration is staggering. These people should not be managing a lemonade stand, much less all federal cancer research," Murray said in a statement. Since taking office in February, Kennedy has overseen massive overhauls of the health system. Beginning in April, nearly 10,000 people were estimated to be laid off, including entire offices at the Food and Drug Administration, Centers for Disease Control and Prevention and NIH. Hundreds of employees were later hired back after public outcry or internal agency discussions over the impact, leaving the full scope of the layoffs unclear. Research cuts have also been a consistent tenet of Kennedy's HHS. Despite the secretary's repeated claims that scientific research was not hit by the cuts, the NIH had released $1.6 billion less in funding by April of this year compared to last year -- a reduction of one-fifth -- according to a New York Times analysis. Other grants have been cut completely because the administration has deemed them ideologically at odds with the president's agenda.
